CADENCE FURTH: Open Payments
NPI 1255968376 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 28 payments from 12 companies in 2025. Trend: 2023 $992 · 2024 $683 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| PFIZER INC. | 4 | $66 |
| ABIOMED | 2 | $50 |
| Amgen Inc. | 3 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Flowphysix Inc | 2 | $34 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| AGEPHA Pharma FZ LLC | 1 | $24 |
Products named: LEQVIO, ELIQUIS, REPATHA, LifeVest, CAMZYOS, FLOWRUNNER, ONPATTRO, FARXIGA.
Industry payments across NC — which companies pay providers there.
